Journey Historical Financial Ratios

DERM Stock  USD 5.44  0.28  5.43%   
Journey Medical is lately reporting on over 90 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as PTB Ratio of 3.5 or Days Sales Outstanding of 66.66 will help investors to properly organize and evaluate Journey Medical Corp financial condition quickly.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Journey Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

About Journey Financial Ratios Analysis

Journey Medical CorpFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Journey Medical investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Journey financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Journey Medical history.

Journey Medical Financial Ratios Chart

At this time, Journey Medical's PFCF Ratio is very stable compared to the past year. As of the 11th of December 2024, EV To Operating Cash Flow is likely to grow to 19.10, while PTB Ratio is likely to drop 3.50.
Add Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Operating CyclePrice Book Value Ratio
Price Earnings To Growth RatioDays Of Payables Outstanding
Dividend Payout RatioPrice To Operating Cash Flows Ratio
Price To Free Cash Flows RatioPretax Profit Margin
Ebt Per EbitOperating Profit Margin
Effective Tax RateCompany Equity Multiplier
Long Term Debt To CapitalizationTotal Debt To Capitalization
Return On Capital EmployedDebt Equity Ratio
Ebit Per RevenueQuick Ratio
Dividend Paid And Capex Coverage RatioNet Income Per E B T
Cash RatioCash Conversion Cycle
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Journey Medical Corp stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Journey Medical sales, a figure that is much harder to manipulate than other Journey Medical Corp multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Ev To Sales

The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.

Inventory Turnover

A ratio showing how many times a company's inventory is sold and replaced over a period, indicating the efficiency of inventory management.
Most ratios from Journey Medical's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Journey Medical Corp current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Journey Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
At this time, Journey Medical's PFCF Ratio is very stable compared to the past year. As of the 11th of December 2024, EV To Operating Cash Flow is likely to grow to 19.10, while PTB Ratio is likely to drop 3.50.
 2021 2022 2023 2024 (projected)
Payables Turnover1.410.831.471.4
Days Of Inventory On Hand112.19167.93139.73132.74

Journey Medical fundamentals Correlations

-0.07-0.22-0.070.05-0.13-0.25-0.070.97-0.09-0.43-0.28-0.560.43-0.26-0.150.35-0.14-0.20.11-0.240.430.02-0.11-0.24-0.02
-0.070.12-0.120.470.55-0.031.0-0.090.570.670.740.53-0.490.60.13-0.340.340.140.070.07-0.490.31-0.60.440.58
-0.220.120.79-0.27-0.520.610.12-0.41-0.50.23-0.23-0.220.53-0.21-0.390.56-0.15-0.690.08-0.470.530.49-0.31-0.190.16
-0.07-0.120.79-0.46-0.80.38-0.12-0.23-0.790.06-0.5-0.590.67-0.47-0.440.88-0.21-0.570.12-0.350.670.3-0.24-0.29-0.11
0.050.47-0.27-0.460.64-0.470.470.090.720.580.560.55-0.440.56-0.32-0.50.360.220.170.49-0.45-0.23-0.140.510.15
-0.130.55-0.52-0.80.64-0.240.55-0.030.990.330.680.85-0.890.640.48-0.910.310.48-0.140.5-0.89-0.35-0.30.460.15
-0.25-0.030.610.38-0.47-0.24-0.03-0.33-0.29-0.29-0.36-0.130.26-0.420.290.24-0.55-0.24-0.41-0.430.270.21-0.32-0.58-0.09
-0.071.00.12-0.120.470.55-0.03-0.090.570.670.740.53-0.490.60.13-0.340.340.140.070.07-0.490.31-0.60.440.58
0.97-0.09-0.41-0.230.09-0.03-0.33-0.090.0-0.45-0.19-0.490.31-0.18-0.080.21-0.10.010.09-0.180.31-0.020.0-0.190.0
-0.090.57-0.5-0.790.720.99-0.290.570.00.390.70.85-0.860.670.37-0.890.350.45-0.070.51-0.86-0.33-0.290.510.18
-0.430.670.230.060.580.33-0.290.67-0.450.390.710.6-0.40.74-0.37-0.270.680.120.420.31-0.410.17-0.270.80.44
-0.280.74-0.23-0.50.560.68-0.360.74-0.190.70.710.73-0.730.950.14-0.690.490.480.010.1-0.730.3-0.080.650.75
-0.560.53-0.22-0.590.550.85-0.130.53-0.490.850.60.73-0.860.710.3-0.890.510.380.060.54-0.86-0.23-0.180.650.2
0.43-0.490.530.67-0.44-0.890.26-0.490.31-0.86-0.4-0.73-0.86-0.69-0.580.9-0.31-0.630.22-0.511.00.320.19-0.49-0.17
-0.260.6-0.21-0.470.560.64-0.420.6-0.180.670.740.950.71-0.690.05-0.650.570.450.070.12-0.690.21-0.080.720.69
-0.150.13-0.39-0.44-0.320.480.290.13-0.080.37-0.370.140.3-0.580.05-0.49-0.290.37-0.60.0-0.57-0.2-0.24-0.23-0.03
0.35-0.340.560.88-0.5-0.910.24-0.340.21-0.89-0.27-0.69-0.890.9-0.65-0.49-0.33-0.570.14-0.460.90.28-0.05-0.47-0.18
-0.140.34-0.15-0.210.360.31-0.550.34-0.10.350.680.490.51-0.310.57-0.29-0.330.230.820.52-0.32-0.070.010.960.18
-0.20.14-0.69-0.570.220.48-0.240.140.010.450.120.480.38-0.630.450.37-0.570.23-0.130.32-0.63-0.180.170.310.14
0.110.070.080.120.17-0.14-0.410.070.09-0.070.420.010.060.220.07-0.60.140.82-0.130.40.22-0.030.10.67-0.07
-0.240.07-0.47-0.350.490.5-0.430.07-0.180.510.310.10.54-0.510.120.0-0.460.520.320.4-0.52-0.8-0.090.56-0.55
0.43-0.490.530.67-0.45-0.890.27-0.490.31-0.86-0.41-0.73-0.861.0-0.69-0.570.9-0.32-0.630.22-0.520.330.19-0.5-0.17
0.020.310.490.3-0.23-0.350.210.31-0.02-0.330.170.3-0.230.320.21-0.20.28-0.07-0.18-0.03-0.80.330.15-0.10.83
-0.11-0.6-0.31-0.24-0.14-0.3-0.32-0.60.0-0.29-0.27-0.08-0.180.19-0.08-0.24-0.050.010.170.1-0.090.190.15-0.060.03
-0.240.44-0.19-0.290.510.46-0.580.44-0.190.510.80.650.65-0.490.72-0.23-0.470.960.310.670.56-0.5-0.1-0.060.25
-0.020.580.16-0.110.150.15-0.090.580.00.180.440.750.2-0.170.69-0.03-0.180.180.14-0.07-0.55-0.170.830.030.25
Click cells to compare fundamentals

Journey Medical Account Relationship Matchups

Journey Medical fundamentals Accounts

201920202021202220232024 (projected)
Price To Sales Ratio4.533.551.480.461.331.26
Ptb Ratio57.5115.382.221.985.163.5
Days Sales Outstanding198.12196.13133.62139.7670.1766.66
Book Value Per Share0.170.622.430.971.121.06
Free Cash Flow Yield0.04180.0248(0.13)(1.0)0.0022850.0024
Operating Cash Flow Per Share0.540.31(0.13)(0.77)0.290.3
Stock Based Compensation To Revenue0.0068730.0034360.03910.06010.03290.0313
Capex To Depreciation1.90.793.914.581.31.23
Pb Ratio57.5115.382.221.985.163.5
Ev To Sales4.553.490.710.331.21.14
Free Cash Flow Per Share0.40.24(0.7)(1.91)0.01320.0138
Roic0.290.37(0.52)(0.69)(0.0579)(0.0608)
Inventory Turnover12.2910.393.252.172.612.48
Net Income Per Share0.220.32(2.54)(1.69)(0.21)(0.22)
Days Of Inventory On Hand29.735.11112.19167.93139.73132.74
Payables Turnover5.07.461.410.831.471.4
Research And Ddevelopement To Revenue22.991.90.260.150.09520.0905
Capex To Revenue0.06870.02690.160.270.06310.0598
Cash Per Share0.290.492.831.831.51.43
Pocfratio17.5530.84(42.72)(2.49)20.0421.04
Interest Coverage20.6211.25(3.6)(13.63)(1.22)(1.28)
Capex To Operating Cash Flow0.270.23(4.59)(1.48)0.951.0
Pfcf Ratio23.9140.25(7.65)(1.0)437.58459.46
Days Payables Outstanding73.0648.92259.52438.63248.48236.05
Income Quality2.490.970.04960.46(1.36)(1.29)
Roe1.320.51(1.05)(1.74)(0.19)(0.18)
Ev To Operating Cash Flow17.6130.29(20.63)(1.82)18.1919.1
Pe Ratio43.6629.96(2.12)(1.14)(27.26)(25.89)
Ev To Free Cash Flow23.9939.53(3.69)(0.73)397.12416.98
Earnings Yield0.02290.0334(0.47)(0.88)(0.0367)(0.0385)
Intangibles To Total Assets0.0050040.220.290.130.260.28
Net Debt To E B I T D A0.078(0.3)1.470.39(5.05)(4.8)
Current Ratio1.211.261.641.161.351.28
Receivables Turnover1.841.862.732.615.24.94
Graham Number0.92.111.786.072.32.19
Shareholders Equity Per Share0.170.622.430.971.121.06
Debt To Equity3.710.510.211.340.870.91

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Journey Medical Corp is a strong investment it is important to analyze Journey Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Journey Medical's future performance. For an informed investment choice regarding Journey Stock, refer to the following important reports:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Journey Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Journey Medical. If investors know Journey will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Journey Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.92)
Revenue Per Share
2.921
Quarterly Revenue Growth
(0.58)
Return On Assets
(0.17)
Return On Equity
(1.30)
The market value of Journey Medical Corp is measured differently than its book value, which is the value of Journey that is recorded on the company's balance sheet. Investors also form their own opinion of Journey Medical's value that differs from its market value or its book value, called intrinsic value, which is Journey Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Journey Medical's market value can be influenced by many factors that don't directly affect Journey Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Journey Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Journey Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Journey Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.